Clinical Trial

CercaTest™ Red Urine Test for Predicting Preeclampsia

Study acronym: PRE-CERCA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to predict preeclampsia in pregnant women aged 18 years or older with a singleton pregnancy at 20 or more weeks of gestation who present with suspected signs or symptoms of preeclampsia. The main questions it aims to answer is: \- Can a next-generation point-of-care urine test (CercaTest™ Red) accurately predict preeclampsia in women with suspected preeclampsia? Participants will be informed and asked to sign a written consent to participate in the study. Complete standard clinical assessments for suspected preeclampsia, including evaluations for new-onset hypertension, proteinuria, maternal end-organ dysfunction, or uteroplacental dysfunction. A urine sample is required to be evaluated using the CercaTest™ Red point-of-care diagnostic test.
Trial Details
NCT Number NCT07625501
Lead Sponsor Chinese University of Hong Kong
Conditions Preeclampsia
Enrollment 1,000 participants
Start Date 2026-01-31
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04